Rakesh Ahuja

Rakesh Ahuja is an Analyst at Acorn Bioventures, a venture capital firm dedicated to investments across the broader biotechnology and life sciences sector. In this role, he is responsible for sourcing new deals, evaluating early-stage investment opportunities, and executing financial transactions with initial ticket sizes ranging from $100,000 to $5,000,000 per company. His daily responsibilities involve conducting rigorous technical due diligence on emerging therapeutics, clinical-stage drug development programs, and advanced healthcare technologies to support the firm's ongoing portfolio expansion. By analyzing complex clinical data, regulatory pathways, and shifting market dynamics, he assists the investment committee in identifying promising biotech startups that align with the fund's strategic mandate. Ahuja's current professional focus remains entirely centered on deploying venture capital into innovative biotechnology enterprises and supporting the long-term operational growth of Acorn Bioventures' expanding healthcare investment portfolio.